Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$8.54B |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$6.22B |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$6.12B |
| 4 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$5.39B |
| 5 |
Schwab 5-10 Year Corporate Bond ETF
SCHI
|
+$5.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$367M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$335M |
| 3 |
Diageo
DEO
|
+$297M |
| 4 |
Medtronic
MDT
|
+$259M |
| 5 |
GE Aerospace
GE
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.36% |
| 2 | Financials | 10.66% |
| 3 | Healthcare | 9.68% |
| 4 | Consumer Discretionary | 8.35% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Fortrea Holdings
FTRE
$1.82B
| $13.1M | ﹤0.01% |
561,143
-5,866
| -1% | -$182K |
|
1902
Golar LNG
GLNG
$5B
| $13.1M | ﹤0.01% |
417,613
-42,362
| -9% | -$1.12M |
|
1903
Nu Skin
NUS
$252M
| $13.1M | ﹤0.01% |
1,241,988
-147,217
| -11% | -$1.87M |
|
|
AHRT
1904
AH Realty Trust
AHRT
$529M
| $13.1M | ﹤0.01% |
1,180,313
-362,691
| -24% | -$3.96M |
|
1905
Ligand Pharmaceuticals
LGND
$5.76B
| $13.1M | ﹤0.01% |
155,340
+5,564
| +4% | +$443K |
|
1906
PAR Technology
PAR
$699M
| $13.1M | ﹤0.01% |
277,256
+57,203
| +26% | +$2.53M |
|
|
AKRO
1907
DELISTED
Akero Therapeutics
AKRO
| $13M | ﹤0.01% |
554,865
+36,579
| +7% | +$782K |
|
1908
Nurix Therapeutics
NRIX
$2.41B
| $13M | ﹤0.01% |
623,404
-18,786
| -3% | -$293K |
|
1909
Coupang
CPNG
$29.3B
| $13M | ﹤0.01% |
620,870
+165,859
| +36% | +$3.6M |
|
1910
Enviri
NVRI
$623M
| $13M | ﹤0.01% |
1,503,785
-215,970
| -13% | -$1.8M |
|
1911
Gulfport Energy Corp
GPOR
$2.9B
| $13M | ﹤0.01% |
85,885
+6,080
| +8% | +$953K |
|
1912
AMC Global Media
AMCX
$492M
| $12.9M | ﹤0.01% |
1,336,197
-271,607
| -17% | -$3.58M |
|
1913
Teekay Tankers
TNK
$2.75B
| $12.9M | ﹤0.01% |
186,999
-8,140
| -4% | -$529K |
|
1914
Berkshire Hathaway Class A
BRK.A
$1.1T
| $12.9M | ﹤0.01% |
21
-65
| -76% | -$40.1M |
|
1915
Columbus McKinnon
CMCO
$553M
| $12.8M | ﹤0.01% |
371,943
+8,330
| +2% | +$338K |
|
|
NXRT
1916
NexPoint Residential Trust
NXRT
$666M
| $12.8M | ﹤0.01% |
323,885
+10,544
| +3% | +$370K |
|
|
DVAX
1917
DELISTED
Dynavax Technologies
DVAX
| $12.8M | ﹤0.01% |
1,137,573
+58,702
| +5% | +$683K |
|
1918
American Healthcare REIT
AHR
$10.7B
| $12.8M | ﹤0.01% |
873,621
+551,653
| +171% | +$7.79M |
|
1919
Array Technologies
ARRY
$803M
| $12.7M | ﹤0.01% |
1,240,390
+17,265
| +1% | +$219K |
|
1920
Vera Therapeutics
VERA
$2.3B
| $12.7M | ﹤0.01% |
351,088
+12,663
| +4% | +$502K |
|
1921
VSE Corp
VSEC
$5.45B
| $12.6M | ﹤0.01% |
143,196
+24,206
| +20% | +$1.94M |
|
1922
KE Holdings
BEKE
$18.7B
| $12.6M | ﹤0.01% |
890,795
+101,610
| +13% | +$1.59M |
|
1923
Kura Oncology
KURA
$800M
| $12.6M | ﹤0.01% |
610,846
+12,122
| +2% | +$249K |
|
1924
Payoneer
PAYO
$2.42B
| $12.6M | ﹤0.01% |
2,269,901
+148,155
| +7% | +$801K |
|
|
RYZ
1925
Ryerson Holding Corp
RYZ
$1.44B
| $12.6M | ﹤0.01% |
644,200
+164,039
| +34% | +$4.23M |
|
Similar funds
Charles Schwab's Q2 2024 Portfolio in Review
As of Q2 2024, Charles Schwab held 3,738 positions worth $525B, up 21% from $433B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Charles Schwab deployed $84.3B of net new capital in Q2 2024, opening 263 new positions and adding to 2,391 existing holdings. Its largest new stake was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Texas Instruments, an estimated $367M trimmed.
- Charles Schwab's largest Q2 2024 buy was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
- Charles Schwab added most to Schwab Fundamental US Large Company Index ETF in Q2 2024, an estimated $8.54B increase.
- Charles Schwab's biggest Q2 2024 reduction was Texas Instruments, cutting an estimated $367M.
- Charles Schwab fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $335M.
- Charles Schwab's ten largest holdings make up 21% of its $525B portfolio in Q2 2024.
- Charles Schwab opened 263 new positions and closed 116 in Q2 2024.
- Charles Schwab's portfolio value rose 21% quarter-over-quarter to $525B.
Based on Charles Schwab's 13F filing for Q2 2024, filed 12 Aug 2024.